Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fields

Showing results (271-280 of 290) with videos related to

Pageof 29
Sort By:
Acta Anaesthesiologica Scandinavica|May 15, 2008
Morphine, opioids, and the feline pulmonary vascular bedA D Kaye, J M Hoover, A J Kaye, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1996
New anticancer agentsG R Weiss, H A Burris 3rd, J R Eckardt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1995
Initial phase I evaluation of the novel thymidylate synthase inhibitor, LY231514, using the modified continual reassessment method for dose escalationD A Rinaldi, H A Burris, F A Dorr, et al.
American Journal of Clinical Oncology|December 1, 1994
A phase II trial of DaunoXome, liposome-encapsulated daunorubicin, in patients with metastatic adenocarcinoma of the colonJ R Eckardt, E Campbell, H A Burris, et al.
JACC. Case Reports|March 21, 2025
Valve-in-Valve TAVR Complicated by Left Main Coronary Obstruction Salvaged by Left Atrial VA-ECMOHafez Golzarian, Abdelrahman Osman, Anna C Kleman, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
An EYA3/NF-κB/CCL2 signaling axis suppresses cytotoxic NK cells in the pre-metastatic niche to promote triple negative breast cancer metastasisSheera R Rosenbaum, Connor J Hughes, Kaiah M Fields, et al.
Science (New York, N.Y.)|November 6, 2010
Collaborative non-self recognition system in S-RNase-based self-incompatibilityKen-ichi Kubo, Tetsuyuki Entani, Akie Takara, et al.
Cancer Research|December 15, 1993
A randomized phase I trial of chronic oral etoposide with or without granulocyte-macrophage colony-stimulating factor in patients with advanced malignanciesD W Shaffer, L S Smith, H A Burris, et al.
Scientific Reports|October 1, 2025
Zooplankton mortality and distribution around a seismic surveyEmilie Hernes Vereide, Anne Christine Utne-Palm, Josefin Titelman, et al.
Investigational New Drugs|September 18, 1998
A phase I and pharmacokinetic trial of terephthalamidine (NSC 57155) as a 120-hour continuous infusionG I Rodriguez, J G Kuhn, G Weiss, et al.
Pageof 29

Showing results (271-280 of 290) with videos related to

Sort By:
Pageof 29
Acta Anaesthesiologica Scandinavica|May 15, 2008
Morphine, opioids, and the feline pulmonary vascular bedA D Kaye, J M Hoover, A J Kaye, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1996
New anticancer agentsG R Weiss, H A Burris 3rd, J R Eckardt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1995
Initial phase I evaluation of the novel thymidylate synthase inhibitor, LY231514, using the modified continual reassessment method for dose escalationD A Rinaldi, H A Burris, F A Dorr, et al.
American Journal of Clinical Oncology|December 1, 1994
A phase II trial of DaunoXome, liposome-encapsulated daunorubicin, in patients with metastatic adenocarcinoma of the colonJ R Eckardt, E Campbell, H A Burris, et al.
JACC. Case Reports|March 21, 2025
Valve-in-Valve TAVR Complicated by Left Main Coronary Obstruction Salvaged by Left Atrial VA-ECMOHafez Golzarian, Abdelrahman Osman, Anna C Kleman, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
An EYA3/NF-κB/CCL2 signaling axis suppresses cytotoxic NK cells in the pre-metastatic niche to promote triple negative breast cancer metastasisSheera R Rosenbaum, Connor J Hughes, Kaiah M Fields, et al.
Science (New York, N.Y.)|November 6, 2010
Collaborative non-self recognition system in S-RNase-based self-incompatibilityKen-ichi Kubo, Tetsuyuki Entani, Akie Takara, et al.
Cancer Research|December 15, 1993
A randomized phase I trial of chronic oral etoposide with or without granulocyte-macrophage colony-stimulating factor in patients with advanced malignanciesD W Shaffer, L S Smith, H A Burris, et al.
Scientific Reports|October 1, 2025
Zooplankton mortality and distribution around a seismic surveyEmilie Hernes Vereide, Anne Christine Utne-Palm, Josefin Titelman, et al.
Investigational New Drugs|September 18, 1998
A phase I and pharmacokinetic trial of terephthalamidine (NSC 57155) as a 120-hour continuous infusionG I Rodriguez, J G Kuhn, G Weiss, et al.
Pageof 29